دورية أكاديمية

Structural insights into the complex of oncogenic KRas4B G12V and Rgl2, a RalA/B activator.

التفاصيل البيبلوغرافية
العنوان: Structural insights into the complex of oncogenic KRas4B G12V and Rgl2, a RalA/B activator.
المؤلفون: Tariq M; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK., Ikeya T; https://ror.org/00ws30h19 Department of Chemistry, Tokyo Metropolitan University, Hachioji, Japan., Togashi N; https://ror.org/00ws30h19 Department of Chemistry, Tokyo Metropolitan University, Hachioji, Japan., Fairall L; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.; https://ror.org/04h699437 Leicester Institute of Structure and Chemical Biology, University of Leicester, Leicester, UK., Kamei S; https://ror.org/00ws30h19 Department of Chemistry, Tokyo Metropolitan University, Hachioji, Japan., Mayooramurugan S; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK., Abbott LR; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK., Hasan A; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK., Bueno-Alejo C; https://ror.org/04h699437 Leicester Institute of Structure and Chemical Biology, University of Leicester, Leicester, UK., Sukegawa S; https://ror.org/00ws30h19 Department of Chemistry, Tokyo Metropolitan University, Hachioji, Japan., Romartinez-Alonso B; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.; https://ror.org/04h699437 Leicester Institute of Structure and Chemical Biology, University of Leicester, Leicester, UK., Muro Campillo MA; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK., Hudson AJ; https://ror.org/04h699437 Leicester Institute of Structure and Chemical Biology, University of Leicester, Leicester, UK.; https://ror.org/04h699437 Department of Chemistry, University of Leicester, Leicester, UK., Ito Y; https://ror.org/00ws30h19 Department of Chemistry, Tokyo Metropolitan University, Hachioji, Japan., Schwabe JW; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.; https://ror.org/04h699437 Leicester Institute of Structure and Chemical Biology, University of Leicester, Leicester, UK., Dominguez C; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.; https://ror.org/04h699437 Leicester Institute of Structure and Chemical Biology, University of Leicester, Leicester, UK., Tanaka K; https://ror.org/04h699437 Department of Molecular and Cell Biology, University of Leicester, Leicester, UK kt96@le.ac.uk.
المصدر: Life science alliance [Life Sci Alliance] 2023 Oct 13; Vol. 7 (1). Date of Electronic Publication: 2023 Oct 13 (Print Publication: 2024).
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: Life Science Alliance, LLC Country of Publication: United States NLM ID: 101728869 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 2575-1077 (Electronic) Linking ISSN: 25751077 NLM ISO Abbreviation: Life Sci Alliance Subsets: MEDLINE
أسماء مطبوعة: Original Publication: [Woodbury, NY] : Life Science Alliance, LLC, [2018]-
مواضيع طبية MeSH: Monomeric GTP-Binding Proteins*/metabolism, Humans ; Signal Transduction/genetics ; Protein Isoforms/metabolism ; Genes, ras
مستخلص: About a quarter of total human cancers carry mutations in Ras isoforms. Accumulating evidence suggests that small GTPases, RalA, and RalB, and their activators, Ral guanine nucleotide exchange factors (RalGEFs), play an essential role in oncogenic Ras-induced signalling. We studied the interaction between human KRas4B and the Ras association (RA) domain of Rgl2 (Rgl2 RA ), one of the RA-containing RalGEFs. We show that the G12V oncogenic KRas4B mutation changes the interaction kinetics with Rgl2 RA The crystal structure of the KRas4B G12V : Rgl2 RA complex shows a 2:2 heterotetramer where the switch I and switch II regions of each KRas G12V interact with both Rgl2 RA molecules. This structural arrangement is highly similar to the HRas E31K :RALGDS RA crystal structure and is distinct from the well-characterised Ras:Raf complex. Interestingly, the G12V mutation was found at the dimer interface of KRas4B G12V with its partner. Our study reveals a potentially distinct mode of Ras:effector complex formation by RalGEFs and offers a possible mechanistic explanation for how the oncogenic KRas4B G12V hyperactivates the RalA/B pathway.
(© 2023 Tariq et al.)
References: J Biol Chem. 1997 Feb 28;272(9):5600-5. (PMID: 9038168)
Chem Sci. 2020 Aug 19;11(34):9272-9289. (PMID: 34094198)
PLoS Comput Biol. 2018 Sep 10;14(9):e1006458. (PMID: 30199525)
FEBS Lett. 1999 May 21;451(2):175-80. (PMID: 10371160)
Protein Eng. 1995 Feb;8(2):127-34. (PMID: 7630882)
Structure. 2015 Jul 7;23(7):1325-35. (PMID: 26051715)
Biochemistry. 1998 Sep 29;37(39):13453-62. (PMID: 9753431)
Science. 2001 Nov 9;294(5545):1299-304. (PMID: 11701921)
Oncogene. 1996 Jul 18;13(2):353-62. (PMID: 8710374)
J Biomol NMR. 1996 Sep;8(2):136-46. (PMID: 8914272)
Proteins. 2005 Jun 1;59(4):687-96. (PMID: 15815974)
Annu Rev Pathol. 2009;4:127-50. (PMID: 18767981)
J Biomol NMR. 2015 Aug;62(4):453-71. (PMID: 25801209)
Proc Natl Acad Sci U S A. 2020 Feb 18;117(7):3363-3364. (PMID: 32047043)
Biochem J. 2016 Jun 15;473(12):1719-32. (PMID: 27057007)
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15500-5. (PMID: 16223883)
Int J Oncol. 1999 Jan;14(1):53-62. (PMID: 9863009)
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):355-67. (PMID: 21460454)
Nat Chem Biol. 2014 Mar;10(3):223-30. (PMID: 24441586)
Cell. 2000 Dec 8;103(6):931-43. (PMID: 11136978)
J Mol Biol. 2022 May 15;434(9):167527. (PMID: 35257782)
Proc Natl Acad Sci U S A. 1984 Sep;81(18):5704-8. (PMID: 6148751)
Mol Syst Biol. 2011 Oct 11;7:539. (PMID: 21988835)
Mol Cancer Res. 2015 Sep;13(9):1325-35. (PMID: 26037647)
Oncogene. 2011 Aug 11;30(32):3477-88. (PMID: 21577205)
EMBO J. 1990 Aug;9(8):2351-9. (PMID: 2196171)
Biochemistry. 1997 Jul 29;36(30):9109-19. (PMID: 9230043)
J Biol Chem. 1996 Nov 22;271(47):29903-8. (PMID: 8939933)
Appl Plant Sci. 2015 May 06;3(5):. (PMID: 25995974)
Science. 1997 Jul 18;277(5324):333-8. (PMID: 9219684)
Cancer Cell. 2004 Apr;5(4):375-87. (PMID: 15093544)
Elife. 2018 Oct 15;7:. (PMID: 30320548)
ACS Chem Biol. 2008 Jun 20;3(6):373-82. (PMID: 18533659)
Proc Natl Acad Sci U S A. 2019 Aug 6;116(32):15823-15829. (PMID: 31332011)
EMBO J. 2008 Jul 23;27(14):1995-2005. (PMID: 18596699)
Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):. (PMID: 33653954)
J Am Chem Soc. 2017 Sep 27;139(38):13466-13475. (PMID: 28863262)
Genes (Basel). 2022 Jan 25;13(2):. (PMID: 35205266)
Proc Natl Acad Sci U S A. 1985 Jan;82(2):376-80. (PMID: 2982154)
Genes Cancer. 2011 Mar;2(3):216-31. (PMID: 21779495)
NPJ Syst Biol Appl. 2021 Feb 12;7(1):10. (PMID: 33580066)
Int Rev Cell Mol Biol. 2021;361:21-105. (PMID: 34074494)
Biochem Biophys Res Commun. 2001 Feb 2;280(4):992-7. (PMID: 11162624)
IUCrJ. 2014 May 30;1(Pt 4):213-20. (PMID: 25075342)
Cancer Cell. 2005 Jun;7(6):533-45. (PMID: 15950903)
Science. 2018 Apr 27;360(6387):423-427. (PMID: 29700264)
J Biomol NMR. 2012 Jul;53(3):209-21. (PMID: 22689066)
Nature. 1984 Aug 23-29;310(5979):644-9. (PMID: 6147754)
J Biol Chem. 2010 Nov 5;285(45):34729-40. (PMID: 20801877)
Small GTPases. 2010 Jul;1(1):2-27. (PMID: 21686117)
Adv Protein Chem. 2003;66:27-85. (PMID: 14631816)
J Biol Chem. 2019 Feb 8;294(6):2193-2207. (PMID: 30559287)
J Cell Biol. 2003 Jan 20;160(2):165-70. (PMID: 12527752)
Int J Oncol. 1999 Aug;15(2):271-9. (PMID: 10402237)
Protein Eng. 2001 Dec;14(12):993-1000. (PMID: 11809930)
Methods Mol Biol. 2009;498:297-307. (PMID: 18988033)
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501. (PMID: 20383002)
Nat Commun. 2021 Feb 19;12(1):1176. (PMID: 33608534)
Proc Natl Acad Sci U S A. 2022 Jan 4;119(1):. (PMID: 34983849)
EMBO J. 1997 Nov 17;16(22):6748-61. (PMID: 9362489)
Chem Sci. 2021 Sep 7;12(38):12827-12837. (PMID: 34703570)
J Phys Chem B. 2022 Feb 24;126(7):1504-1519. (PMID: 35142524)
Mol Cell. 2006 Feb 17;21(4):495-507. (PMID: 16483931)
Cancer Res. 2007 Mar 1;67(5):2098-106. (PMID: 17332339)
Cell. 2017 Jun 29;170(1):17-33. (PMID: 28666118)
Biochem J. 2008 Oct 1;415(1):145-54. (PMID: 18540861)
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14. (PMID: 23793146)
Mol Cell Biol. 2014 Mar;34(5):862-76. (PMID: 24366544)
Angew Chem Int Ed Engl. 2020 Jun 26;59(27):11037-11045. (PMID: 32227412)
Sci Rep. 2017 Jan 09;7:40109. (PMID: 28067274)
J Am Chem Soc. 2011 Feb 2;133(4):880-7. (PMID: 21141956)
Biochem Biophys Res Commun. 1997 Sep 18;238(2):425-9. (PMID: 9299525)
Genes Cancer. 2011 Mar;2(3):275-87. (PMID: 21779498)
Cell. 1986 Jan 17;44(1):167-76. (PMID: 3510078)
Curr Biol. 2006 Dec 19;16(24):2385-94. (PMID: 17174914)
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674. (PMID: 19461840)
Sci Rep. 2017 Jan 24;7:41297. (PMID: 28117393)
Nature. 1991 Jun 13;351(6327):576-9. (PMID: 1904555)
J Mol Biol. 2006 Jan 27;355(4):821-44. (PMID: 16310215)
Nat Struct Biol. 1998 Jun;5(6):422-6. (PMID: 9628477)
Proc Natl Acad Sci U S A. 2015 May 26;112(21):6625-30. (PMID: 25941399)
Biochem Biophys Res Commun. 2003 Jun 13;305(4):934-40. (PMID: 12767920)
Mol Cell. 2019 Feb 21;73(4):830-844.e12. (PMID: 30639242)
J Am Chem Soc. 2013 Feb 6;135(5):1688-91. (PMID: 23327446)
Methods Mol Biol. 2002;189:13-24. (PMID: 12094582)
معلومات مُعتمدة: United Kingdom WT_ Wellcome Trust; 204801/Z/16/Z United Kingdom WT_ Wellcome Trust; BB/T00746X/1 United Kingdom BB_ Biotechnology and Biological Sciences Research Council
سلسلة جزيئية: PDB 1LFD; 1RLF; 6VJJ; 7SCW; 7SCX; 1HE8; 2C5L; 3DDC; 5P21; 8B69; 8AU4
المشرفين على المادة: EC 3.6.5.2 (Monomeric GTP-Binding Proteins)
0 (Protein Isoforms)
تواريخ الأحداث: Date Created: 20231013 Date Completed: 20231023 Latest Revision: 20240210
رمز التحديث: 20240210
مُعرف محوري في PubMed: PMC10576006
DOI: 10.26508/lsa.202302080
PMID: 37833074
قاعدة البيانات: MEDLINE
الوصف
تدمد:2575-1077
DOI:10.26508/lsa.202302080